Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer

[1]  K. Egan,et al.  Heterogeneity in prognostic value of the neutrophil-to-lymphocyte ratio: a meta-analysis , 2019 .

[2]  P. Rutkowski,et al.  Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure. , 2019, Oncology letters.

[3]  W. Du,et al.  Significance of the neutrophil-to-lymphocyte ratio in young patients with oral squamous cell carcinoma , 2019, Cancer management and research.

[4]  R. Motzer,et al.  MP21-04 NEUTROPHIL-TO-LYMPHOCYTE RATIO IN UNCLASSIFIED RENAL CELL CARCINOMA IS ASSOCIATED WITH PROGNOSIS AND VARIES BETWEEN MOLECULAR SUBGROUPS , 2019, Journal of Urology.

[5]  S. Shariat,et al.  Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis. , 2018, Urologic oncology.

[6]  A. Nayak,et al.  Elevated Preoperative Neutrophil–Lymphocyte Ratio is Predictive of a Poorer Prognosis for Pediatric Patients with Solid Tumors , 2017, Annals of Surgical Oncology.

[7]  Lu Shi,et al.  Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies. , 2017, Cancer Treatment Reviews.

[8]  L. Ferrucci,et al.  Changes in blood lymphocyte numbers with age in vivo and their association with the levels of cytokines/cytokine receptors , 2016, Immunity & Ageing.

[9]  E. Uribe-Querol,et al.  Neutrophils in Cancer: Two Sides of the Same Coin , 2015, Journal of immunology research.

[10]  Xinxiang Li,et al.  Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy , 2015, Oncotarget.

[11]  R. Uzzo,et al.  Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma. , 2015, Urologic oncology.

[12]  Z. Granot,et al.  Promoting metastasis: neutrophils and T cells join forces , 2015, Cell Research.

[13]  J. Jonkers,et al.  IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis , 2015, Nature.

[14]  J. Spicer,et al.  Neutrophil extracellular traps in cancer progression , 2014, Cellular and Molecular Life Sciences.

[15]  I. Tannock,et al.  Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. , 2014, Journal of the National Cancer Institute.

[16]  Jiayin Yang,et al.  Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation. , 2013, World journal of gastroenterology.

[17]  S. Clarke,et al.  The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. , 2013, Critical reviews in oncology/hematology.

[18]  S. Hao,et al.  Detection of immune suppressive neutrophils in peripheral blood samples of cancer patients. , 2013, American journal of blood research.

[19]  L. Koenderman,et al.  Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences , 2013, Cellular and Molecular Life Sciences.

[20]  P. Hunter.  The inflammation theory of disease , 2012, EMBO reports.

[21]  M. Köbel,et al.  Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes , 2012, Journal of Translational Medicine.

[22]  Leo Koenderman,et al.  A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. , 2012, The Journal of clinical investigation.

[23]  D. McMillan.  Systemic inflammation, nutritional status and survival in patients with cancer , 2009, Current opinion in clinical nutrition and metabolic care.

[24]  K. Honn,et al.  Inflammation and disease progression , 2006, Cancer and Metastasis Reviews.

[25]  J. Everhart,et al.  Benign Ethnic Neutropenia in Individuals of African Descent: Incidence, Granulocyte Mobilization, and Gene Expression Profiling. , 2005 .

[26]  G. Basso,et al.  c-Met Oncogene Enhances Fas-Mediated Apoptosis in B-ALL t(12;21) Cells. , 2005 .

[27]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[28]  John O'Quigley,et al.  An application of changepoint methods in studying the effect of age on survival in breast cancer , 1999 .

[29]  M. Chun,et al.  Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer , 2015, Tumor Biology.

[30]  R. Záhorec.  Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. , 2001, Bratislavske lekarske listy.